University WebRUSL MailLMSERPNoticesRight to Information (RTI)Help DeskContact us
Menu

Publications

  1. Warnasekara J, Srimantha S, Kappagoda C, et al. Diagnostic method-based underestimation of leptospirosis in clinical and research settings; an experience from a large prospective study in a high endemic setting. Poonawala H, ed. PLoS Negl Trop Dis. 2022;16(4):e0010331. doi:10.1371/journal.pntd.0010331
  1. Senavirathna I, Jayasundara D, Warnasekara J, Matthias MA, Vinetz JM, Agampodi S. Complete genome sequences of twelve strains of Leptospira interrogans isolated from humans in Sri Lanka. Infect Genet Evol. 2023 Sep;113:105462. doi: 10.1016/j.meegid.2023.105462. Epub 2023 Jun 8. PMID: 37301334.
  1. Jayasundara D, Senavirathna I, Warnasekara J, et al. 12 Novel clonal groups of Leptospira infecting humans in multiple contrasting epidemiological contexts in Sri Lanka. Lau CL, ed. PLoS Negl Trop Dis. 2021;15(3):e0009272. doi:10.1371/journal.pntd.0009272
  1. Senevirathna I, Jayasundara D, Lefler JP, Kira C, Warnasekara J, et al. Complete Genome Sequence of Leptospira interrogans Strains FMAS_KW1, FMAS_KW2 and FMAS_AW1 Isolated from Leptospirosis Patients from Karawanalla and Awissawella, Sri Lanka. J Genomics. 2020. doi:10.7150/jgen.43953
  1. Jayasundara D, Gamage C, Senavirathna I, Warnasekara J, et al. Optimizing the microscopic agglutination test (MAT) panel for the diagnosis of Leptospirosis in a low resource, hyper-endemic setting with varied microgeographic variation in reactivity. Neela V kumari, ed. PLoS Negl Trop Dis. 2021;15(7):e0009565. doi:10.1371/journal.pntd.0009565
  1. Senavirathna I, Jayasundara D, Warnasekara J, Kappagoda C, Agampodi S. Levels of Cytokines in Leptospirosis Patients with Different Serovars and rfb Locus. J Interferon Cytokine Res. 2024 Feb;44(2):80-93. doi: 10.1089/jir.2023.0091. PMID: 38377491; PMCID: PMC10880283.
  1. Senavirathna I, Jayasundara D, Warnasekara J, Matthias MA, Vinetz JM, Agampodi S. Whole genome sequencing data of Leptospira weilii and Leptospira kirschneri isolated from human subjects of Sri Lanka. Data Brief. 2023 Nov 22;52:109840. doi: 10.1016/j.dib.2023.109840. PMID: 38059003; PMCID: PMC10696454.
  1. Agampodi S, Warnasekara J, Siribaddana S, et al. Demographic, exposure, clinical, biochemical and diagnostic data of febrile patients recruited for the largest field study on leptospirosis in Sri Lanka. Data Br. 2022;43:108378. doi:10.1016/J.DIB.2022.108378
  1. Agampodi S, Warnasekara J, Jayasundara D, et al. Study protocol: characterising the clinical, epidemiological and aetiological aspects of leptospirosis in Sri Lanka: a hospital based clinico-epidemiological study. BMJ Open. 2019;9(9):e027850. doi:10.1136/bmjopen-2018-027850
  1. Warnasekara J, Agampodi S. Neglecting the neglected during the COVID-19 pandemic; the case of leptospirosis in Sri Lanka. Epidemiol Health. 2022;44:e2022015. doi:10.4178/epih.e2022015
  1. Warnasekara J, Agampodi S, Abeynayake R. R. Time series models for prediction of leptospirosis in different climate zones in Sri Lanka. Zeng Q, ed. PLoS One. 2021;16(5):e0248032. doi:10.1371/journal.pone.0248032
  1. Warnasekara J, Srimantha SM, Agampodi SB. Estimating the burden of leptospirosis: global lessons from Sri Lanka. BMJ Glob Heal. 2021;6(10):e006946. doi:10.1136/bmjgh-2021-006946
  1. Warnasekara J, Koralegedara I, Agampodi S. Estimating the burden of leptospirosis in Sri Lanka; A systematic review. BMC Infect Dis. 2019;19(1). doi:10.1186/s12879-018-3655-y
  1. Warnasekara J, Srimantha S, Senavirathna I, et al. The variable presence of Leptospira in the environment; an epidemiological explanation based on serial analysis of water samples. Wooten RM, ed. PLoS One. 2022;17(2):e0263719. doi:10.1371/journal.pone.0263719
  1. Warnasekara J, Aberathna P, Nanayakkara G, Vinetz J, Agampodi S. Improving the leptospirosis disease burden assessment by including ambulatory patients from outpatient departments: a cross-sectional study. F1000Research. 2020;9:1129. doi:10.12688/f1000research.26202.1
  1. Warnasekara JN, Agampodi S. Leptospirosis in Sri Lanka. Sri Lankan J Infect Dis. 2017;7(2):67. doi:10.4038/sljid.v7i2.8155
  1. Warnasekara, J., Agampodi, S., & NR, A. (2022). SARIMA and ARDL models for predicting leptospirosis in Anuradhapura district Sri Lanka. PLOS ONE, 17(10). doi:10.1371/journal.pone.0275447
  1. Dahanayaka NJ, Agampodi SB, Seneviratna I, Warnasekara J, Rajapakse R, Ranathunga K et al. Clinical spectrum of endemic leptospirosis in relation to cytokine response. PLoS One. 2021;16(12):e0261025. doi:10.1371/journal.pone.0261025
  1. Dahanayaka NJ, Warnasekara YPJN, Rajapakse RMSR, Ranathunga SYK, Agampodi SB. Validity of Lateral Flow Immunochromatographic-Assays (LFIA) in diagnosis of leptospirosis. Ceylon Med J. 2017;62(4):248. doi:10.4038/cmj.v62i4.8579
  1. Schønning MH, Phelps MD, Warnasekara J, Agampodi SB, Furu P. A Case–Control Study of Environmental and Occupational Risks of Leptospirosis in Sri Lanka. Ecohealth. 2019;16(3):534-543. doi:10.1007/s10393-019-01448-w